E. Schäfer

IBD-related Malignancies Observed in 2015–2019 : 4 Years’ Results from the Prospective, Nationwide Hungarian Registry IBD-related Malignancies – Hungarian Registry

K. Farkas, F. Nagy, T. Molnár, 2021, Central European Journal of Gastroenterology and Hepatology.

Comparison of Elisa-Based Tyrosine Kinase Assays for Screening EGFR Inhibitors

G. Kéri, I. Peták, T. Gyökeres, 2005, Journal of receptor and signal transduction research.

Hungarian Linguistic, Cross-Cultural, and Age Adaptation of the Patient Satisfaction with Health Care in Inflammatory Bowel Disease Questionnaire (CACHE) and the Medication Adherence Report Scale (MARS)

P. Hegyi, A. Erős, A. Párniczky, 2022, Children.

Real-life efficacy of vedolizumab on endoscopic healing in inflammatory bowel disease – A nationwide Hungarian cohort study

K. Farkas, F. Nagy, T. Molnár, 2019, Expert opinion on biological therapy.

Early diagnosis of pancreatobiliary duct malignancies by brush cytology and biopsy

G. Elek, T. Gyökeres, Á. Pap, 2008, Pathology & Oncology Research.

Ustekinumab is associated with superior treatment persistence but not with higher remission rates versus vedolizumab in patients with refractory Crohn’s disease: results from a multicentre cohort study

K. Farkas, T. Molnár, P. Sarlós, 2022, Therapeutic advances in gastroenterology.

Patient and general population values for luminal and perianal fistulising Crohn’s disease health states

P. Lakatos, P. Stalmeier, M. Péntek, 2019, The European Journal of Health Economics.

[Introduction of a quality index in a Hungarian endoscopy unit].

J. Banai, T. Gyökeres, T. Szamosi, 2012, Orvosi hetilap.